pentoxifylline has been researched along with Thrombosis in 36 studies
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Shunt thrombosis was assumed when the flow in the shunt discontinued under visual and auscultatory control." | 6.66 | Shunt thrombosis prevention in hemodialysis patients--a double-blind, randomized study: pentoxifylline vs placebo. ( Borić, Z; Muśikić, P; Naumović, T; Radmilović, A; Stamenković, M, 1987) |
| "injection inhibited thrombus formation in small mesenteric vessels for more than 12 hours but less than 24 hours." | 5.28 | [Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis]. ( Bielawiec, M; Breddin, HK; Krupiński, K; Płonowski, A, 1992) |
| "The authors studied the effect of pentoxifylline (Trental), a hemorrheologic agent that increases erythrocyte flexibility and augments microcirculatory blood flow, on the patency of a known thrombosis model." | 3.69 | The use of pentoxifylline in microvascular surgery. ( Ferder, M; Hunzicker, K; Kronen, G; Strauch, B, 1994) |
| "The hamster cheek pouch model of experimental thrombosis in which thrombi are induced in the microvasculature by iontophoretical administration of adenosine diphosphate (ADP) was used to test the antithrombotic potential of pentoxifylline (Trental)." | 3.67 | Reduced thrombus formation in vivo after administration of pentoxifylline (Trental). ( Giessinger, N; Michal, M; Schröer, R, 1989) |
| "The effect of the combined oral administration of pentoxifylline (pof) and low dose acetylsalicylic acid (ASA) was evaluated with the help of the laser-induced thrombosis in rat mesenteric arterioles." | 3.67 | Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation. ( Seiffge, D; Weithmann, KU, 1987) |
| "Shunt thrombosis was assumed when the flow in the shunt discontinued under visual and auscultatory control." | 2.66 | Shunt thrombosis prevention in hemodialysis patients--a double-blind, randomized study: pentoxifylline vs placebo. ( Borić, Z; Muśikić, P; Naumović, T; Radmilović, A; Stamenković, M, 1987) |
| "Counterproductive lung inflammation and dysregulated thrombosis contribute importantly to the lethality of advanced COVID-19." | 1.56 | Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole. ( Barroso-Aranda, J; DiNicolantonio, JJ, 2020) |
| "injection inhibited thrombus formation in small mesenteric vessels for more than 12 hours but less than 24 hours." | 1.28 | [Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis]. ( Bielawiec, M; Breddin, HK; Krupiński, K; Płonowski, A, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (44.44) | 18.7374 |
| 1990's | 7 (19.44) | 18.2507 |
| 2000's | 8 (22.22) | 29.6817 |
| 2010's | 2 (5.56) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bayraktar, S | 1 |
| Tanyeri-Bayraktar, B | 1 |
| Assimakopoulos, SF | 1 |
| Seintis, F | 1 |
| Marangos, M | 1 |
| DiNicolantonio, JJ | 1 |
| Barroso-Aranda, J | 1 |
| Plotnikov, MB | 1 |
| Smolyakova, VI | 1 |
| Ivanov, IS | 1 |
| Kuchin, AV | 1 |
| Chukicheva, IJ | 1 |
| Krasnov, EA | 1 |
| Diskin, CJ | 2 |
| Jenkins, J | 1 |
| Babu, K | 1 |
| Hsu-Hung, E | 1 |
| Robinson-Bostom, L | 1 |
| Kroumpouzos, G | 1 |
| Melnik, B | 1 |
| Hariry, H | 1 |
| Vakilzadeh, F | 1 |
| Gropp, C | 1 |
| Sitzer, G | 1 |
| Murthy, P | 1 |
| Riesberg, MV | 1 |
| Hart, S | 1 |
| Bustillo, A | 1 |
| Duque, CS | 1 |
| Said, S | 1 |
| Civantos, FJ | 1 |
| Hödl, S | 1 |
| Usküdar, O | 1 |
| Erdem, A | 1 |
| Demiroğlu, H | 1 |
| Dikmenoğlu, N | 1 |
| Il'in, VN | 2 |
| Stepanov, NV | 1 |
| Ikhaev, ZA | 1 |
| Sharonin, GV | 1 |
| Bogdanets, LI | 1 |
| Dintenfass, L | 1 |
| Lucas, MA | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Stadler, S | 1 |
| Toumbis, C | 1 |
| Markus, G | 1 |
| Kronen, G | 1 |
| Ferder, M | 1 |
| Hunzicker, K | 1 |
| Strauch, B | 1 |
| de Prost, D | 1 |
| Colen, LB | 1 |
| Stevenson, A | 1 |
| Sidorov, V | 1 |
| Potparic, Z | 1 |
| Pacelli, E | 1 |
| Searles, J | 1 |
| Lee, S | 1 |
| Li, L | 1 |
| Stokes, TJ | 1 |
| Thomas, SG | 1 |
| Ravis, W | 1 |
| Lock, S | 1 |
| Thomas, J | 1 |
| Panus, LW | 1 |
| Dansby, L | 1 |
| Carter, T | 1 |
| Poliantsev, AA | 1 |
| Spasov, AA | 1 |
| Mozgovoĭ, PV | 1 |
| Karpenko, AV | 1 |
| Shcherbakov, VN | 1 |
| Kuznetsov, VI | 1 |
| Khomutnikova, AI | 1 |
| Kirichenko, OM | 1 |
| Souza, CS | 1 |
| Roselino, AM | 1 |
| Figueiredo, F | 1 |
| Foss, NT | 1 |
| Jaimes, EA | 1 |
| Castillo, DD | 1 |
| Rutherford, MS | 1 |
| Raij, L | 1 |
| Shestakov, VA | 2 |
| Rodionov, SV | 1 |
| Danilova, LM | 1 |
| Müller, R | 2 |
| Zatevakhin, II | 1 |
| Koshkin, VM | 2 |
| Il'in, SG | 1 |
| Adil'khanov, SG | 2 |
| Antonova, NIu | 1 |
| Lehrach, F | 1 |
| Theis, H | 1 |
| Krupiński, K | 1 |
| Breddin, HK | 2 |
| Bielawiec, M | 1 |
| Płonowski, A | 1 |
| Vyalov, SL | 1 |
| Rekhter, MD | 1 |
| Sidorov, VB | 1 |
| Pshenisnov, KP | 1 |
| Mironov, AA | 1 |
| Michal, M | 1 |
| Giessinger, N | 1 |
| Schröer, R | 1 |
| Neugodov, IuV | 1 |
| Sokolov, GF | 1 |
| Popov, VV | 1 |
| El'skaia, IE | 1 |
| Seiffge, D | 2 |
| Weithmann, KU | 2 |
| Radmilović, A | 1 |
| Borić, Z | 1 |
| Naumović, T | 1 |
| Stamenković, M | 1 |
| Muśikić, P | 1 |
| Weichert, W | 1 |
| Schröer, RH | 1 |
| Kovaleva, LG | 1 |
| Sedova, GT | 1 |
| Krasiukova, LI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pentoxifylline Dose Optimization in Preterm Neonatal Late Onset Sepsis[NCT04152980] | Phase 3 | 40 participants (Anticipated) | Interventional | 2020-01-12 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for pentoxifylline and Thrombosis
| Article | Year |
|---|---|
Novel insights into the pathobiology of the vascular access - do they translate into improved care?
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Arteriovenous Shunt, Surgical; Calcium Cha | 2010 |
Action of drugs on the aggregation and deformability of red cells: effect of ABO blood groups.
Topics: ABO Blood-Group System; Alprenolol; Blood Coagulation; Blood Viscosity; Cell Adhesion; Erythrocyte A | 1983 |
Pentoxifylline: a potential treatment for thrombosis associated with abnormal tissue factor expression by monocytes and endothelial cells.
Topics: Endothelium, Vascular; Humans; Monocytes; Pentoxifylline; Thromboplastin; Thrombosis; Vasodilator Ag | 1995 |
Pentoxifylline -- a biomedical profile.
Topics: Arterial Occlusive Diseases; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Erythrocy | 1979 |
3 trials available for pentoxifylline and Thrombosis
| Article | Year |
|---|---|
Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
Topics: Aged; Aspirin; Dipyridamole; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; P | 1984 |
[Antithrombotic prophylaxis after surgical interventions on the major veins].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Dextrans; Drug Combinations; Drug Evaluation; Fem | 1978 |
Shunt thrombosis prevention in hemodialysis patients--a double-blind, randomized study: pentoxifylline vs placebo.
Topics: Adult; Aged; Aged, 80 and over; Arteriovenous Shunt, Surgical; Clinical Trials as Topic; Double-Blin | 1987 |
29 other studies available for pentoxifylline and Thrombosis
| Article | Year |
|---|---|
Pentoxifylline in the treatment of neonatal vasospasm and thromboembolism: An observational case series study.
Topics: Humans; Infant, Newborn; Pentoxifylline; Retrospective Studies; Spasm; Thromboembolism; Thrombosis | 2022 |
Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.
Topics: Antibodies, Monoclonal, Humanized; Betacoronavirus; Blood Coagulation Disorders; Coronavirus Infecti | 2020 |
Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
Topics: Adenosine A2 Receptor Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; C | 2020 |
Antithrombogenic and antiplatelet activity of optho-isobornyl phenol derivative.
Topics: Animals; Brain Ischemia; Camphanes; Cresols; Fibrinolytic Agents; Male; Pentoxifylline; Platelet Agg | 2008 |
ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation.
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Aspirin; Biopsy, Needle; Cocaine-Re | 2011 |
[Malignant atrophic papulosis (Köhlmeier-Degos disease). Failure to respond to interferon alpha-2a, pentoxifylline and aspirin].
Topics: Aspirin; Atrophy; Connective Tissue; Diagnosis, Differential; Disease Progression; Drug Therapy, Com | 2002 |
Efficacy of perioperative thromboprophylactic agents in the maintenance of anastamotic patency and survival of rat microvascular free groin flaps.
Topics: Abdomen; Anastomosis, Surgical; Animals; Anticoagulants; Femoral Artery; Groin; Heparin, Low-Molecul | 2003 |
[Treatment of freezing injury].
Topics: Blood Viscosity; Cell Death; Cold Temperature; Combined Modality Therapy; Endothelium, Vascular; Foo | 2005 |
Decreased erythrocyte deformability in Behçet's disease.
Topics: Adult; Behcet Syndrome; Case-Control Studies; Erythrocyte Deformability; Female; Humans; Male; Middl | 2005 |
[Postoperative antithrombotic therapy in acute occlusion of the major arteries of the extremities].
Topics: Acute Disease; Adolescent; Adult; Aged; Arm; Arterial Occlusive Diseases; Aspirin; Dextrans; Female; | 1980 |
Potentiation of thrombolytic therapy by enzyme combinations and with aspirin or pentoxifylline.
Topics: Animals; Aspirin; Drug Synergism; Drug Therapy, Combination; Macaca; Pentoxifylline; Platelet Aggreg | 1994 |
The use of pentoxifylline in microvascular surgery.
Topics: Animals; Double-Blind Method; Femoral Artery; Injections, Intraperitoneal; Microcirculation; Microsu | 1994 |
Microvascular anastomotic thrombosis in experimental diabetes mellitus.
Topics: Anastomosis, Surgical; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Angiopathie | 1997 |
An analysis of the effect of routine medications on hemodialysis vascular access survival.
Topics: Arteriovenous Shunt, Surgical; Humans; Pentoxifylline; Phosphodiesterase Inhibitors; Proportional Ha | 1998 |
[Prevention of early thrombotic complications after reconstructive operations in occlusions of the aorto-iliac segment].
Topics: Adult; Aged; Anticoagulants; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Aspirin | 2000 |
Lucio's phenomenon: clinical and therapeutic aspects.
Topics: Aged; Anti-Inflammatory Agents; Brazil; Disease Progression; Endothelium, Vascular; Fatal Outcome; F | 2000 |
Countervailing influence of tumor necrosis factor-alpha and nitric oxide in endotoxemia.
Topics: Analysis of Variance; Animals; Endotoxemia; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Es | 2001 |
[Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction].
Topics: Acute Disease; Blood Viscosity; Hemostasis; Humans; Papaverine; Pentoxifylline; Theobromine; Thrombo | 1979 |
[Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Circulation; Drug Evaluation; Embolism; Hemodynami | 1979 |
[5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Eye Diseases; | 1977 |
[Evaluation of the antithrombotic effects of pentoxifylline, acetylsalicylic acid and low molecular weight heparin in the laser model of thrombosis].
Topics: Animals; Aspirin; Disease Models, Animal; Heparin, Low-Molecular-Weight; In Vitro Techniques; Lasers | 1992 |
Formation of endovasal structures and intramural channels in rat vena cava after application of microsurgical suture: prophylactic effect of heparin and trental administration.
Topics: Anastomosis, Surgical; Animals; Blood Platelets; Connective Tissue; Endothelium, Vascular; Fibrin; H | 1992 |
Reduced thrombus formation in vivo after administration of pentoxifylline (Trental).
Topics: Adenosine Diphosphate; Animals; Cheek; Cricetinae; Fibrinolytic Agents; Injections, Intraperitoneal; | 1989 |
[The onset of circulatory venous gangrene of the arm and its successful treatment by thrombolysis].
Topics: Adult; Arm; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gangrene; Heparin; Humans; Infus | 1989 |
Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
Topics: Animals; Aspirin; Blood Flow Velocity; Blood Viscosity; Dose-Response Relationship, Drug; Drug Thera | 1989 |
Surprising effects of the sequential administration of pentoxifylline and low dose acetylsalicylic acid on thrombus formation.
Topics: Administration, Oral; Animals; Aspirin; Drug Administration Schedule; Drug Synergism; Lasers; Male; | 1987 |
Antithrombotic effects of acetylsalicylic acid (ASA) and pentoxifylline in laser-induced thrombosis in rat mesenteric vessels.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; In Vitro Techniques; Laser Therapy; Male; Mesent | 1985 |
Antithrombotic potential of pentoxifylline. A hemorheologically active drug.
Topics: Animals; Aspirin; Blood Coagulation; Cricetinae; Epoprostenol; Fibrinolysis; Haplorhini; Hemostasis; | 1985 |
[Preventive correction of hemostasis in patients with polycythemia vera].
Topics: Aspirin; Humans; Niacin; Pentoxifylline; Polycythemia Vera; Theobromine; Thrombosis | 1986 |